Reference price system initially applying to 4,557 drugs.

Published: 2001-09-24 07:00:00

Updated: 2001-09-24 07:00:00

In the policy debate over the Reference Price System on Sept. 19 Mr. Han Oh-suk, the chief officer of the Survey and Research Institute of the Health Insurance Review Agency (HIRA) indicated under his presentation titled "The reference price system review: A foreign application case and how to ap...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK